<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/F136CFEA-9D85-4AD1-A276-8B691226C2E4" ns1:id="F136CFEA-9D85-4AD1-A276-8B691226C2E4"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/D17B1134-E478-41B4-95DD-728943D633F9" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/0B8830B4-FCFB-4AA6-8C38-2A3CF9C7D1C5" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/0B8830B4-FCFB-4AA6-8C38-2A3CF9C7D1C5" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2020-12-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/54A1EE4F-2A9E-46B6-BF32-AD0BAB1BA53C" ns1:rel="FUND" ns1:start="2020-09-30T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">80686</ns2:identifier></ns2:identifiers><ns2:title>Technical Feasibility for an Early Cannulation Vascular Access Graft with SLF(TM) Technology</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Small Business Research Initiative</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Vascular Flow Technologies intend to build on the success of the Spiral Laminar Flow Vascular Access Graft by developing the best treatment possible for dialysis patients. The development of an **Early Cannulation Access Graft coupled with the patented Spiral Laminar Flow technology will allow immediate use of the graft post implantation**. By developing in-house end-to-end manufacturing, Vascular Flow Technologies will firmly establish itself as a leading vascular graft manufacturer with facilities based in the UK. **Phase 1** of the project will address the technical feasibility and explore design for manufacture options and evaluate new and existing technologies. **Phase 2** of the project will ultimately lead to Vascular Flow Technologies setting up full scale expanded polytetraflurorethylene (ePTFE) graft manufacturing, capitalising on existing assets and creating long term supply chain security.</ns2:abstractText></ns2:project>